These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10389048)

  • 1. Vascular cognitive disorder.
    Sachdev P
    Int J Geriatr Psychiatry; 1999 May; 14(5):402-3. PubMed ID: 10389048
    [No Abstract]   [Full Text] [Related]  

  • 2. Utilization of the Dementia Rating Scale-2 and cognitive enhancers in the diagnosis and treatment of cognitive disorders and dementia.
    Caston JC; Diehl LA; Hedgepath AW
    J S C Med Assoc; 2004 Feb; 100(2):32-8. PubMed ID: 15040232
    [No Abstract]   [Full Text] [Related]  

  • 3. The neuropsychology of vascular dementia.
    Wetzel ME; Kramer JH
    Handb Clin Neurol; 2008; 88():567-83. PubMed ID: 18631713
    [No Abstract]   [Full Text] [Related]  

  • 4. Mild cognitive impairment subtypes and vascular dementia.
    Visser PJ
    J Am Geriatr Soc; 2006 Dec; 54(12):1966-7; author reply 1967-8. PubMed ID: 17198525
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment and prediction of functional impairment in vascular dementia.
    Boyle PA; Cahn-Weiner D
    Expert Rev Neurother; 2004 Jan; 4(1):109-14. PubMed ID: 15853621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vascular dementia and vascular cognitive impairment].
    Qian CY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):198-200. PubMed ID: 15171562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An experimental, randomized, double-blind, placebo-controlled clinical trial to infestigate the effect of nicardipine on cognitive function in patients with vascular dementia. Spanish group of nicardipine study in vascular dementia].
    Rev Neurol; 1999 May 1-15; 28(9):835-45. PubMed ID: 10390744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frontal Behavioural Inventory in the differential diagnosis of dementia.
    Milan G; Lamenza F; Iavarone A; Galeone F; Lorè E; de Falco C; Sorrentino P; Postiglione A
    Acta Neurol Scand; 2008 Apr; 117(4):260-5. PubMed ID: 17922889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive function in schizoaffective disorder and clinical subtypes of schizophrenia.
    Goldstein G; Shemansky WJ; Allen DN
    Arch Clin Neuropsychol; 2005 Mar; 20(2):153-9. PubMed ID: 15708725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to Bigler (2007): the sky is not falling.
    Hom J
    Arch Clin Neuropsychol; 2008 Jan; 23(1):125-8. PubMed ID: 17919883
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1.
    Lopez OL; Jagust WJ; DeKosky ST; Becker JT; Fitzpatrick A; Dulberg C; Breitner J; Lyketsos C; Jones B; Kawas C; Carlson M; Kuller LH
    Arch Neurol; 2003 Oct; 60(10):1385-9. PubMed ID: 14568808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuropsychological profile of vascular cognitive impairment--no dementia: comparisons to patients at risk for cerebrovascular disease and vascular dementia.
    Garrett KD; Browndyke JN; Whelihan W; Paul RH; DiCarlo M; Moser DJ; Cohen RA; Ott BR
    Arch Clin Neuropsychol; 2004 Sep; 19(6):745-57. PubMed ID: 15288328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar patterns of cognitive deficits in the preclinical phases of vascular dementia and Alzheimer's disease.
    Laukka EJ; Jones S; Small BJ; Fratiglioni L; Bäckman L
    J Int Neuropsychol Soc; 2004 May; 10(3):382-91. PubMed ID: 15147596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Discriminatory validity and association of the mini-mental test (MMSE) and the memory alteration test (M@T) with a neuropsychological battery in patients with amnestic mild cognitive impairment and Alzheimer's disease].
    Rami L; Bosch B; Valls-Pedret C; Caprile C; Sánchez-Valle Díaz R; Molinuevo JL
    Rev Neurol; 2009 Aug 16-31; 49(4):169-74. PubMed ID: 19621317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive consequences of multiple lacunes and leukoaraiosis as vascular cognitive impairment in community-dwelling elderly individuals.
    Koga H; Takashima Y; Murakawa R; Uchino A; Yuzuriha T; Yao H
    J Stroke Cerebrovasc Dis; 2009 Jan; 18(1):32-7. PubMed ID: 19110142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.
    Kalbe E; Calabrese P; Kohn N; Hilker R; Riedel O; Wittchen HU; Dodel R; Otto J; Ebersbach G; Kessler J
    Parkinsonism Relat Disord; 2008; 14(2):93-101. PubMed ID: 17707678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Introduction: how to examine a patient with cognitive disorders].
    Takeda K
    No To Shinkei; 2005 May; 57(5):357-63. PubMed ID: 15981634
    [No Abstract]   [Full Text] [Related]  

  • 18. Feasibility of telecognitive assessment in dementia.
    Cullum CM; Weiner MF; Gehrmann HR; Hynan LS
    Assessment; 2006 Dec; 13(4):385-90. PubMed ID: 17050908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The Japanese version of RBANS (Repeatable Battery for the Assessment of Neuropsychological Status)].
    Yamashima T; Yoshida M; Kumahashi K; Matsui M; Koshino Y; Higashima M; Nagasawa T; Ueki A; Ohtsuka M; Aoki S; Imuro S; Mori N; Takei N; Hoshino R; Minabe Y; Nanba Y; Nanba M; Kira J; Ohyagi Y; Haraoka J; Akimoto J; Miura N; Kimura S; Matsushita M
    No To Shinkei; 2002 Jun; 54(6):463-71. PubMed ID: 12166095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment.
    Mitchell AJ
    J Psychiatr Res; 2009 Jan; 43(4):411-31. PubMed ID: 18579155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.